In prostate cancer-derived CAFs (PCa-CAFs), AR modulates the tumor-promoting abilities of CAFs, with low AR expression in CAFs associated with heightened stem cell marker gene expression in cancer epithelial cells. This evidence concerns the gene AR and cancer.